PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
20.94%
Some net income increase while AVGO is negative at -203.80%. John Neff would see a short-term edge over the struggling competitor.
0.33%
Less D&A growth vs. AVGO's 321.31%, reducing the hit to reported earnings. David Dodd would confirm that core assets remain sufficient.
52.63%
Some yoy growth while AVGO is negative at -250.00%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
-19.48%
Negative yoy SBC while AVGO is 83.33%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
165.88%
Less working capital growth vs. AVGO's 7400.00%, indicating potentially more efficient day-to-day cash usage. David Dodd would confirm no negative impact on revenue.
125.45%
AR growth well above AVGO's 175.00%. Michael Burry would fear inflated sales or less stringent credit controls vs. competitor.
76.67%
Inventory shrinking or stable vs. AVGO's 1533.33%, indicating lean supply management. David Dodd would confirm no demand shortfall.
18.64%
A yoy AP increase while AVGO is negative at -387.50%. John Neff would see competitor possibly improving relationships or liquidity more rapidly.
18200.00%
Some yoy usage while AVGO is negative at -1160.00%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
130.00%
Lower 'other non-cash' growth vs. AVGO's 450.00%, indicating steadier reported figures. David Dodd would confirm no missed necessary write-downs or gains.
78.45%
Operating cash flow growth above 1.5x AVGO's 25.10%. David Dodd would confirm superior cost control or stronger revenue-to-cash conversion.
-28.75%
Both yoy lines negative, with AVGO at -30.14%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
28.75%
Acquisition growth of 28.75% while AVGO is zero at 0.00%. Bruce Berkowitz sees a mild outflow that must deliver synergy to justify the difference.
-69.64%
Negative yoy purchasing while AVGO stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
-68.16%
Both yoy lines are negative, with AVGO at -100.00%. Martin Whitman suspects an environment prompting fewer sales or fewer maturities within the niche.
-18.18%
Both yoy lines negative, with AVGO at -100.00%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-147.76%
Both yoy lines negative, with AVGO at -9627.12%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
100.00%
Debt repayment growth of 100.00% while AVGO is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
-45.60%
Both yoy lines negative, with AVGO at -2.94%. Martin Whitman suspects an environment or preference for internal financing over new equity in the niche.
9.83%
Buyback growth of 9.83% while AVGO is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.